{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:59:21Z","timestamp":1785283161216,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jdcr.2026.03.061","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:16:58Z","timestamp":1775755018000},"page":"4-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Remission of erythromelalgia after semaglutide initiation: A case report"],"prefix":"10.1016","volume":"72","author":[{"given":"Susanne Sofie","family":"Laugsand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tore","family":"Wergeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Engstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Erik","family":"Laugsand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jdcr.2026.03.061_bib1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archderm.136.3.330","article-title":"Natural history of erythromelalgia: presentation and outcome in 168 patients","volume":"136","author":"Davis","year":"2000","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2026.03.061_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archdermatol.2010.337","article-title":"Nonspecific capillary proliferation and vasculopathy indicate skin hypoxia in erythromelalgia","volume":"147","author":"Kalgaard","year":"2011","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2026.03.061_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1523-1747.2000.00944.x","article-title":"Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia","volume":"114","author":"M\u00f8rk","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"10","key":"10.1016\/j.jdcr.2026.03.061_bib4","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archderm.139.10.1337","article-title":"Erythromelalgia: vasculopathy, neuropathy, or both? a prospective study of vascular and neurophysiologic studies in erythromelalgia","volume":"139","author":"Davis","year":"2003","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2026.03.061_bib5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jamadermatol.2016.4404","article-title":"Epidermal nerve fiber quantification in patients with erythromelalgia","volume":"153","author":"Mantyh","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jdcr.2026.03.061_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3094642","article-title":"Anti-inflammatory effects of GLP-1-based therapies beyond glucose control","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediators Inflamm"},{"issue":"6","key":"10.1016\/j.jdcr.2026.03.061_bib7","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jacbts.2018.09.004","article-title":"The GLP-1- analogs liraglutide and semaglutide reduce atherosclerosis in apoE\u2013\/\u2013 and LDLr\u2013\/\u2013 mice by a mechanism that includes inflammatory pathways","volume":"3","author":"Rakipovski","year":"2018","journal-title":"JACC Basic Transl Sci"},{"issue":"5","key":"10.1016\/j.jdcr.2026.03.061_bib8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/biom15050622","article-title":"Therapeutic effects of GLP-1 receptor agonists and DPP-4 inhibitors in neuropathic pain: mechanisms and clinical implications","volume":"15","author":"Kuthati","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.jdcr.2026.03.061_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109806","article-title":"Glucagon-like peptide-1 receptor agonist attenuates diabetic neuropathic pain via inhibition of NOD-like receptor protein 3 inflammasome in brain microglia","volume":"186","author":"Zhang","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.jdcr.2026.03.061_bib10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626001967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626001967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:26:30Z","timestamp":1785281190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512626001967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":10,"alternative-id":["S2352512626001967"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.03.061","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remission of erythromelalgia after semaglutide initiation: A case report","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.03.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}